Interestingly, hepatic SIRT3 was also reported to be reduced in mouse models of NAFLD and in NASH patients compared with control subjects (23, 31) suggesting a significant role for SIRT3 in NAFLD. This evidence concerns the gene SIRT3 and metabolic dysfunction-associated steatohepatitis.